Viking Therapeutics, Inc. offers promising advances in obesity and liver diseases, despite a recent stock drop over GLP-1 market concerns. Click for my VKTX update.

New recommendations on how to define obesity would reduce the emphasis on body mass index and take into account health ...

By coincidence (they started before GLP -1 drugs were approved for slimming), a group of 56 doctors have just answered that ...

Huge numbers of the 17.6million Brits who have been told that they are overweight are in fact perfectly healthy, the ...

Nearly four in ten (37 per cent) parents say the typically make their children eat everything in front of them.

Get Wall Street's Hottest Chart Every Morning According to JP Morgan ... The conference is scheduled between 13 January and 16 January. Obesity is expected to remain a major focus for the industry.

Chronic inflammation, often fueled by poor diet, stress, and other lifestyle factors, contributes significantly to conditions like diabetes, metabolic syndrome, and obesity. Sen-Jam's innovative ...

Trends in the prevalence of hyperuricemia among adolescents in the US have remained stable over time, with prevalence significantly associated with obesity. A significant percentage of adolescents in ...

Findings show lower use among Black, Hispanic, and Asian adults vs White adults. HealthDay News — Racial and ethnic disparities are seen in the use of obesity-management medications, according ...

But there is an even more worrying aspect. Childhood obesity between 1975 and 2022 has increased 10-fold, and this compromises the dietary habits even of the next generation. Accustomed to eating ...

Asian and Hispanic individuals had significantly lower odds of utilizing obesity-management medications compared with White individuals. (HealthDay News) — Racial and ethnic disparities are ...

Since Zepbound was approved by the FDA to treat obesity in late 2023, its maker Eli Lilly has been steadily closing in on fierce rival Novo Nordisk’s early lead in the obesity market.